The role of cardiovascular magnetic resonance (CMR) and computed tomography (CCT) in facilitating heart failure management

Current Treatment Options in Cardiovascular Medicine

Volumn 15, Issue 4, 2013, Pages 373-386

  Stacey, R Brandon ^a   Hundley, W Gregory ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac computed tomography; Cardiomyopathy; Cardiovascular magnetic resonance; Heart failure; Valvular heart disease

Indexed keywords

GADOLINIUM;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY RECANALIZATION; DIAGNOSTIC ACCURACY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INTERMETHOD COMPARISON; IONIZING RADIATION; ISCHEMIC CARDIOMYOPATHY; NONISCHEMIC CARDIOMYOPATHY; PHARMACOLOGIC STRESS TESTING; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; VALVULAR HEART DISEASE;

EID: 84881070135     PISSN: 10928464     EISSN: 15343189     Source Type: Journal    
DOI: 10.1007/s11936-013-0253-6     Document Type: Review

References (67)

1. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA. 2002;288(17):2144-50.
2. Hundley WG, Kitzman DW, Morgan TM, Hamilton CA, Darty SN, Stewart KP, et al. Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol. 2001;38(3):796-802.
3. Dall'Armellina E, Morgan TM, Mandapaka S, Ntim W, Carr JJ, Hamilton CA, et al. Prediction of cardiac events in patients with reduced left ventricular ejection fraction with dobutamine cardiovascular magnetic resonance assessment of wall motion score index. J Am Coll Cardiol. 2008;52(4):279-86.
4. Lee VS. Black blood imaging. In: Lee VS, editor. Cardiovascular MRI. New York: Lippincott Williams and Wilkins; 2006. p. 274-82.
5. Lightfoot JC, D'Agostino Jr RB, Hamilton CA, Jordan J, Torti FM, Kock ND, et al. Novel approach to early detection of doxorubicin cardiotoxicity by gadolinium-enhanced cardiovascular magnetic resonance imaging in an experimental model. Circ Cardiovasc Imaging. 2010;3(5):550-8.
6. Lee VS. Cine gradient echo imaging. In: Lee VS, editor. Cardiovascular MRI. New York: Lippincott Williams and Wilkins; 2006. p. 283-306.
7. Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA, Friedrich MG, et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol. 2010;55(23):2614-62.
8. Kuhl HP, Spuentrup E, Wall A, Franke A, Schroder J, Heussen N, et al. Assessment of myocardial function with interactive non-breath-hold real-time MR imaging: comparison with echocardiography and breath-hold Cine MR imaging. Radiology. 2004;231(1):198-207.
9. Bellenger NG, Davies LC, Francis JM, Coats AJ, Pennell DJ. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2000;2(4):271-8.
10. Kempny A, Fernandez-Jimenez R, Orwat S, Schuler P, Bunck AC, Maintz D, et al. Quantification of biventricular myocardial function using cardiac magnetic resonance feature tracking, endocardial border delineation and echocardiographic speckle tracking in patients with repaired tetralogy of Fallot and healthy controls. J Cardiovasc Magn Reson. 2012;14:32.
11. Li P, Meng H, Liu SZ, Vannan MA. Quantification of left ventricular mechanics using vector-velocity imaging, a novel feature tracking algorithm, applied to echocardiography and cardiac magnetic resonance imaging. Chin Med J (Engl). 2012;125(15):2719-27.
12. Osman NF, Kerwin WS, McVeigh ER, Prince JL. Cardiac motion tracking using CINE harmonic phase (HARP) magnetic resonance imaging. Magn Reson Med. 1999;42(6):1048-60.
13. Pan L, Prince JL, Lima JA, Osman NF. Fast tracking of cardiac motion using 3D-HARP. IEEE Trans Biomed Eng. 2005;52(8):1425-35.
14. Diller GP, Radojevic J, Kempny A, Alonso-Gonzalez R, Emmanouil L, Orwat S, et al. Systemic right ventricular longitudinal strain is reduced in adults with transposition of the great arteries, relates to subpulmonary ventricular function, and predicts adverse clinical outcome. Am Heart J. 2012;163(5):859-66.
15. Hor KN, Mazur W, Taylor MD, Al-Khalidi HR, Cripe LH, Jefferies JL, et al. Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011;13:60.
16. Schuster A, Morton G, Hussain ST, Jogiya R, Kutty S, Asrress KN, et al. The intra-observer reproducibility of cardiovascular magnetic resonance myocardial feature tracking strain assessment is independent of field strength. Eur J Radiol. 2013;82(2):296-301.
17. Korosoglou G, Futterer S, Humpert PM, Riedle N, Lossnitzer D, Hoerig B, et al. Strain-encoded cardiac MR during high-dose dobutamine stress testing: comparison to cine imaging and to myocardial tagging. J Magn Reson Imaging. 2009;29(5):1053-61.
18. Tandri H, Daya SK, Nasir K, Bomma C, Lima JA, Calkins H, et al. Normal reference values for the adult right ventricle by magnetic resonance imaging. Am J Cardiol. 2006;98(12):1660-4.
19. Lee VS. Phase contrast flow quantification in the heart. In: Lee VS, editor. Cardiovascular MRI. New York: Lippincott Williams and Wilkins; 2006. p. 325-36.
20. Hundley WG, Li HF, Hillis LD, Meshack BM, Lange RA, Willard JE, et al. Quantitation of cardiac output with velocity-encoded, phase-difference magnetic resonance imaging. Am J Cardiol. 1995;75(17):1250-5.
21. Hundley WG, Li HF, Willard JE, Landau C, Lange RA, Meshack BM, et al. Magnetic resonance imaging assessment of the severity of mitral regurgitation. Comparison with invasive techniques. Circulation. 1995;92(5):1151-8.
22. Bernhardt P, Engels T, Levenson B, Haase K, Albrecht A, Strohm O. Prediction of necessity for coronary artery revascularization by adenosine contrast-enhanced magnetic resonance imaging. Int J Cardiol. 2006;112(2):184-90.
23. Lee VS. Tissue characterization in the heart. In: Lee VS, editor. Cardiovascular MRI. New York: Lippincott Williams and Wilkins; 2006. p. 307-24.
24. Menke J, Unterberg-Buchwald C, Staab W, Sohns JM, Seif Amir Hosseini A, Schwarz A. Head-to-head comparison of prospectively triggered vs retrospectively gated coronary computed tomography angiography: Meta-analysis of diagnostic accuracy, image quality, and radiation dose. Am Heart J. 2013;165(2):154-63.
25. Vorre MM, Abdulla J. Diagnostic accuracy and radiation dose of CT coronary angiography in atrial fibrillation: systematic review and meta-analysis. Radiology. 2013;267(2):376-86.
26. Kim JS, Choo KS, Jeong DW, Chun KJ, Park YH, Song SG, et al. Step-and-shoot prospectively ECG-gated vs retrospectively ECG-gated with tube current modulation coronary CT angiography using 128-slice MDCT patients with chest pain: diagnostic performance and radiation dose. Acta Radiol. 2011;52(8):860-5.
27. Martini C, Palumbo A, Maffei E, Rossi A, Rengo M, Malago R, et al. Dose reduction in spiral CT coronary angiography with dual-source equipment. Part I. A phantom study applying different prospective tube current modulation algorithms. Radiol Med. 2009;114(7):1037-52.
28. Yang CC, Mok GS, Law WY, Hsu SM, Wu TH, Chen LK. Potential dose reduction of optimal ECG-controlled tube current modulation for 256-slice CT coronary angiography. Acad Radiol. 2011;18(6):731-7.
29. Feuchtner G, Goetti R, Plass A, Wieser M, Scheffel H, Wyss C, et al. Adenosine stress high-pitch 128-slice dual-source myocardial computed tomography perfusion for imaging of reversible myocardial ischemia: comparison with magnetic resonance imaging. Circ Cardiovasc Imaging. 2011;4(5):540-9.
30. Mendoza DD, Joshi SB, Weissman G, Taylor AJ, Weigold WG. Viability imaging by cardiac computed tomography. J Cardiovasc Comput Tomogr. 2010;4(2):83-91.
31. Raman SV, Shah M, McCarthy B, Garcia A, Ferketich AK. Multi-detector row cardiac computed tomography accurately quantifies right and left ventricular size and function compared with cardiac magnetic resonance. Am Heart J. 2006;151(3):736-44.
32. Sugeng L, Mor-Avi V, Weinert L, Niel J, Ebner C, Steringer-Mascherbauer R, et al. Quantitative assessment of left ventricular size and function: side-by-side comparison of real-time three-dimensional echocardiography and computed tomography with magnetic resonance reference. Circulation. 2006;114(7):654-61.
33. Wallace EL, Morgan TM, Walsh TF, Dall'Armellina E, Ntim W, Hamilton CA, et al. Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease. JACC Cardiovasc Imaging. 2009;2(3):299-307.
34. Korosoglou G, Elhmidi Y, Steen H, Schellberg D, Riedle N, Ahrens J, et al. Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1493 consecutive patients: assessment of myocardial wall motion and perfusion. J Am Coll Cardiol. 2010;56(15):1225-34.
35. Hundley WG, Morgan TM, Neagle CM, Hamilton CA, Rerkpattanapipat P, Link KM. Magnetic resonance imaging determination of cardiac prognosis. Circulation. 2002;106(18):2328-33.
36. Walsh TF, Dall'Armellina E, Chughtai H, Morgan TM, Ntim W, Link KM, et al. Adverse effect of increased left ventricular wall thickness on five year outcomes of patients with negative dobutamine stress. J Cardiovasc Magn Reson. 2009;11:25.
37. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343(20):1445-53.
38. Steel K, Broderick R, Gandla V, Larose E, Resnic F, Jerosch-Herold M, et al. Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation. 2009;120(14):1390-400.
39. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation. 2006;114(15):1581-90.
40. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26(15):1461-74.
41. Thavendiranathan P, Walls M, Giri S, Verhaert D, Rajagopalan S, Moore S, et al. Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping. Circ Cardiovasc Imaging. 2012;5(1):102-10.
42. Cheong BY, Muthupillai R, Nemeth M, Lambert B, Dees D, Huber S, et al. The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2009;26(1):39-46.
43. Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120(20):1969-77.
44. White JA, Patel MR. The role of cardiovascular MRI in heart failure and the cardiomyopathies. Cardiol Clin. 2007;25(1):71-95 vi.
45. Lu MY, Peng SS, Chang HH, Yang YL, Chen CA, Jou ST, et al. Cardiac iron measurement and iron chelation therapy in patients with beta thalassaemia major: experience from Taiwan. Transfus Med. 2013;23(2):100-7.
46. Piga A, Longo F, Musallam KM, Cappellini MD, Forni GL, Quarta G, et al. Assessment and management of iron overload in beta-thalassaemia major patients during the 21st century: a real-life experience from the Italian Webthal project. Br J Haematol. 2013;161(6):872-83.
47. Shamsian BS, Esfahani SA, Milani H, Akhlaghpoor S, Mojtahedzadeh S, Karimi A, et al. Magnetic resonance imaging in the evaluation of iron overload: a comparison of MRI, echocardiography and serum ferritin level in patients with beta-thalassemia major. Clin Imaging. 2012;36(5):483-8.
48. Petersen SE, Selvanayagam JB, Wiesmann F, Robson MD, Francis JM, Anderson RH, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2005;46(1):101-5.
49. Alhabshan F, Smallhorn JF, Golding F, Musewe N, Freedom RM, Yoo SJ. Extent of myocardial non-compaction: comparison between MRI and echocardiographic evaluation. Pediatr Radiol. 2005;35(11):1147-51.
50. Oechslin EN, Attenhofer Jost CH, Rojas JR, Kaufmann PA, Jenni R. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol. 2000;36(2):493-500.
51. Stacey RB, Andersen MM, St. Clair SM, Hundley WG, Thohan V. Comparison of systolic and diastolic criteria for isolated left ventricular noncompaction in cardiac MRI. JACC Cardiovasc Imaging. 2013. doi: 10.1016/j.jcmg.2013.01.014.
52. van Dockum WG, Knaapen P, Hofman MB, Kuijer JP, ten Cate FJ, ten Berg JM, et al. Impact of alcohol septal ablation on left anterior descending coronary artery blood flow in hypertrophic obstructive cardiomyopathy. Int J Cardiovasc Imaging. 2009;25(5):511-8.
53. Maron BJ, Lindberg J, Lesser JR. Ventricular septal crypt in hypertrophic cardiomyopathy. Eur Heart J. 2010;31(15):1923.
54. Maron MS, Olivotto I, Harrigan C, Appelbaum E, Gibson CM, Lesser JR, et al. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation. 2011;124(1):40-7.
55. Defrance C, Bollache E, Kachenoura N, Perdrix L, Hrynchyshyn N, Bruguiere E, et al. Evaluation of aortic valve stenosis using cardiovascular magnetic resonance: comparison of an original semiautomated analysis of phase-contrast cardiovascular magnetic resonance with Doppler echocardiography. Circ Cardiovasc Imaging. 2012;5(5):604-12.
56. Tanaka K, Makaryus AN, Wolff SD. Correlation of aortic valve area obtained by the velocity-encoded phase contrast continuity method to direct planimetry using cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2007;9(5):799-805.
57. Yap SC, van Geuns RJ, Meijboom FJ, Kirschbaum SW, McGhie JS, Simoons ML, et al. A simplified continuity equation approach to the quantification of stenotic bicuspid aortic valves using velocity-encoded cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2007;9(6):899-906.
58. Cawley PJ, Hamilton-Craig C, Owens DS, Krieger EV, Strugnell WE, Mitsumori L, et al. Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography. Circ Cardiovasc Imaging. 2013;6(1):48-57.
59. Feuchtner GM, Muller S, Bonatti J, Schachner T, Velik-Salchner C, Pachinger O, et al. Sixty-four slice CT evaluation of aortic stenosis using planimetry of the aortic valve area. Am J Roentgenol. 2007;189(1):197-203.
60. Jilaihawi H, Doctor N, Kashif M, Chakravarty T, Rafique A, Makar M, et al. Aortic annular sizing for transcatheter aortic valve replacement using cross-sectional 3-dimensional transesophageal echocardiography. J Am Coll Cardiol. 2013;61(9):908-16.
61. Feuchtner GM, Dichtl W, Muller S, Jodocy D, Schachner T, Klauser A, et al. 64-MDCT for diagnosis of aortic regurgitation in patients referred to CT coronary angiography. Am J Roentgenol. 2008;191(1):W1-7.
62. Duckett SG, Chiribiri A, Ginks MR, Sinclair S, Knowles BR, Botnar R, et al. Cardiac MRI to investigate myocardial scar and coronary venous anatomy using a slow infusion of dimeglumine gadobenate in patients undergoing assessment for cardiac resynchronization therapy. J Magn Reson Imaging. 2011;33(1):87-95.
63. Leyva F, Foley PW, Chalil S, Ratib K, Smith RE, Prinzen F, et al. Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011;13:29.
64. Leyva F, Taylor RJ, Foley PW, Umar F, Mulligan LJ, Patel K, et al. Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. J Am Coll Cardiol. 2012;60(17):1659-67.
65. Malago R, Pezzato A, Barbiani C, Sala G, Zamboni GA, Tavella D, et al. Noninvasive cardiac vein mapping: role of multislice CT coronary angiography. Eur J Radiol. 2012;81(11):3262-9.
66. Neizel M, Kramer N, Schutte A, Schnackenburg B, Kruger S, Kelm M, et al. Magnetic resonance imaging of the cardiac venous system and magnetic resonance-guided intubation of the coronary sinus in swine: a feasibility study. Invest Radiol. 2010;45(8):502-6.
67. Saremi F, Muresian H, Sanchez-Quintana D. Coronary veins: comprehensive CT-anatomic classification and review of variants and clinical implications. Radiographics. 2012;32(1):E1-32.